Director/PDMR Shareholding

GW Pharmaceuticals

735.00p

16:34 02/12/16

2.87%

20.50p

RNS Number : 3875E

Howden Joinery Group PLC

16 September 2024

HOWDEN JOINERY GROUP PLC

(the "Company")

NOTIFICATION OF A TRANSACTION IN SHARES BY A PERSON DISCHARGING MANAGERIAL RESPONSIBILITY

On 16 September 2024, Guy Eccles, a person discharging managerial responsibility ("PDMR") in the Company, sold 17,914 ordinary shares in the Company at an average price of 952.51 pence per share.

The Notification of Dealing Form for the above transaction, provided in accordance with the requirements of UK MAR, may be found below.

NOTIFICATION OF DEALING FORM

Details of the person discharging managerial responsibilities / person closely associated

Name

Edward Guy Eccles

Reason for the notification

Position/status

PDMR

Initial notification/ Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Howden Joinery Group Plc

LEI

213800KC1LJOJTY3JP45

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


Nature of transaction	Sale of ordinary 10 pence shares.
Description/type of Financial Instrument	Identification code	Date of transaction	Place of transaction
Ordinary shares of 10 pence each	GB0005576813	2024-09-16	London Stock Exchange (XLON)
Individual transactions	Price(s)	Volume(s)	Total
Individual transactions	GBP 9.5251	17,914	GBP 170,632.64
Aggregated information	Price	Aggregated Volume	Total
Aggregated information	GBP 9.5251	17,914	GBP 170,632.64

Enquiries

Forbes McNaughton, Company Secretary +44 (0)207 535 1110

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFFEASIRLIS